Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection.
Johanna M SweereJonas D Van BelleghemHeather IshakMichelle S BachMedeea C PopescuVivekananda SunkariGernot KaberRobert ManasherobGina A SuhXiou CaoChristiaan R de VriesDung N LamPayton L MarshallMaria BirukovaEthan KatznelsonDaniel V LazzareschiSwathi BalajiSundeep G KeswaniThomas R HawnPatrick R SecorPaul L BollykyPublished in: Science (New York, N.Y.) (2019)
Bacteriophage are abundant at sites of bacterial infection, but their effects on mammalian hosts are unclear. We have identified pathogenic roles for filamentous Pf bacteriophage produced by Pseudomonas aeruginosa (Pa) in suppression of immunity against bacterial infection. Pf promote Pa wound infection in mice and are associated with chronic human Pa wound infections. Murine and human leukocytes endocytose Pf, and internalization of this single-stranded DNA virus results in phage RNA production. This triggers Toll-like receptor 3 (TLR3)- and TIR domain-containing adapter-inducing interferon-β (TRIF)-dependent type I interferon production, inhibition of tumor necrosis factor (TNF), and the suppression of phagocytosis. Conversely, immunization of mice against Pf prevents Pa wound infection. Thus, Pf triggers maladaptive innate viral pattern-recognition responses, which impair bacterial clearance. Vaccination against phage virions represents a potential strategy to prevent bacterial infection.
Keyphrases
- toll like receptor
- pseudomonas aeruginosa
- immune response
- endothelial cells
- inflammatory response
- rheumatoid arthritis
- dendritic cells
- type diabetes
- metabolic syndrome
- staphylococcus aureus
- single molecule
- climate change
- induced pluripotent stem cells
- escherichia coli
- human health
- nucleic acid
- peripheral blood
- candida albicans
- circulating tumor cells